Certified by Founder Lodge
FogPharma
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $145,000,000
0 Participating Investments
-
Founded date
2016
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
FogPharma is developing a new class of drugs to address the limitations of today’s precision medicines and achieve universal druggability. The company is pioneering the discovery, development
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 05 ,2024 | Series E | $145,000,000 |
Sixty Degree Capital
Johnson & Johnson
Foresite Capital
Nextech Invest
RA Capital Management, L.P.
Catalio Capital Management
Rock Springs Capital
Marshall Wace
Samsara BioCapital
SymBiosis(US)
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)